Alkem Labs unveils Ibuprofen, Famotidine Tablets in US

Mumbai: Alkem Laboratories Ltd. today announced the launch of Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the United States, following an approval from the United States Food and Drug Administration (USFDA).

Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis Tablets, 800 mg/26.6 mg.

"This is the first generic approval of Duexis Tablets, 800 mg/26.6 mg by the US FDA. The launch is a subject of ongoing litigation," Alkem Labs said in a release.

Read also: Alkem labs successfully completes USFDA inspection for Taloja Bioequivalence Center

Read also: Alkem Labs launches epilepsy drug Perampil in India